Looking for information about CORPORATE STRATEGY AND RESEARCH SCIENTIFIC OFFICER? Follow the links below to find all the information you are interested in. Addresses, telephones, emails, working hours and other useful information.


New organizational structure brings together Ohio State’s ...

    https://ceo.osu.edu/new-organizational-structure-brings-together-ohio-state%E2%80%99s-research-innovation-and-knowledge
    Apr 02, 2021 · The Office of Research will lead the strategy and efforts to grow Ohio State’s research and creative expression enterprise, including operations, sponsored programs and research compliance. Dr. ... He currently serves as the Chief Scientific Officer for the Wexner Medical Center as well as the Vice Dean for Research for the College of ...

Our Team Inhibrx Meet our experts in biotherapeutics.

    https://inhibrx.com/team/
    Director. Dr. Eckelman co-founded Inhibrx in April 2010 and currently serves as our Chief Scientific Officer and Executive Vice President of Corporate Strategy. From August 2015 to November 2018, he served as our Chief Operating Officer and Vice President of Biotherapeutics. From 2010 until August 2015, Dr. Eckelman served as our Vice President ...Estimated Reading Time: 9 mins

Bodi Zhang - Chief Scientific Officer, Chief of Corporate ...

    https://www.linkedin.com/in/bodi-zhang-2957a022
    Chief Scientific Officer, Chief of Corporate and Medical Strategy at Thorne HealthTech Tufts University School of Medicine View profile View profile badgesWorks For: Thorne Healthtech, Nutrativa

Leadership Incyte.com

    https://www.incyte.com/our-company/our-leadership
    Executive Vice President and Chief Scientific Officer. ... Global Strategy and Corporate Development. ... at Pennie & Edmonds LLP in New York (now part of Jones Day). Before her career in law, Ms. Pasquale was an Assistant Research Scientist at the Institute for Basic Research and the Cold Spring Harbor Laboratory, where she designed and ...

Executive Leadership – Mirati Therapeutics, Inc.

    https://www.mirati.com/about/executive-leadership/
    President and Chief Executive Officer. Charles Baum, M.D., Ph.D. President and Chief Executive Officer. Chuck has served as President, Chief Executive Officer and Board Member of Mirati Therapeutics since 2012. Under his leadership, Mirati has transformed into a precision oncology company focused on advancing drug discovery and research and ...

Research And Development Teams - Foundation Medicine

    https://careers.foundationmedicine.com/research-and-development-teams
    Nov 19, 2020 · Priti Hegde, PhD, Chief Scientific Officer Dr. Hegde joined Foundation Medicine as the Chief Scientific Officer in August 2019. Her team comprises of Cancer Genomics, Research and Early Development, Computational Biology, Translational Strategy, Franchise Development, and Product Development (inclusive of Assay Development, Companion Diagnostic Development Operations, …

Our Team - Rani Therapeutics

    https://www.ranitherapeutics.com/about-us/our-team/
    He joined Boston Scientific in 2005 as Vice President for Corporate Strategy for Japan, where he led business transformation and increased operational efficiency. Prior to joining Boston Scientific, Nanavaty spent 16 years working in various executive positions at Baxter International, Inc., and …

IMV Announces Appointment of Jeremy R. Graff, Ph.D. as ...

    https://www.businesswire.com/news/home/20210609005202/en/IMV-Announces-Appointment-of-Jeremy-R.-Graff-Ph.D.-as-Chief-Scientific-Officer-And-Addition-of-Clinical-Advisor
    Jun 09, 2021 · Dr. Graff will lead IMV’s research to continue the expansion of DPX- based ... Ph.D. as Chief Scientific Officer, effective as of June 14, 2021. Dr. ... He also managed corporate strategy for ...

FibroGen Appoints John Hunter, Ph.D. as Chief Scientific ...

    https://www.biospace.com/article/releases/fibrogen-appoints-john-hunter-ph-d-as-chief-scientific-officer/
    Jul 12, 2021 · SAN FRANCISCO, July 12, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) announced the appointment of John Hunter, Ph.D., to the position of Chief Scientific Officer, where he will lead FibroGen’s research efforts, leveraging more than 20 years of global biopharmaceutical leadership and experience. “Great science and innovation are the backbone of …

About - OmniSeq

    https://www.omniseq.com/about/
    About - OmniSeq. The Right Drug or Trial for Every Patient. This is the OmniSeq Mission. OmniSeq ® was founded with one purpose in mind: To inform physicians and their patients of the most actionable tumor-profiling information possible. We know that, when we accomplish this goal, we’re enabling patients to benefit from personalized ...

In addition to information on CORPORATE STRATEGY AND RESEARCH SCIENTIFIC OFFICER, our site contains many other interesting information about corporate offices. We invite you to view the pages with related information.

Related Corporate Office Information: